IE0005711209 - Common Stock
ICON PLC
NASDAQ:ICLR (4/26/2024, 7:00:02 PM)
After market: 308.31 0 (0%)308.31
+8.23 (+2.74%)
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The company is headquartered in Dublin, Dublin and currently employs 41,150 full-time employees. The firm is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. The company offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The firm's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. The company also provides its full range of clinical, consulting and commercial services across several sectors. Its sectors include Biosimilars, Biotech, Government and public health solutions, medical devices, pharmaceuticals and the IVDR journey.
ICON PLC
South County Business Park, Dublin 18
DUBLIN DUBLIN 00000
P: 35312912000
CEO: Steve Cutler
Employees: 41150
Website: https://www.iconplc.com/
ICLR stock results show that Icon beat analyst estimates for earnings per share but met on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Icon (NASDAQ:ICLR) just reported results for the first quarter of 2024.Icon rep...
Here you can normally see the latest stock twits on ICLR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: